HAS2 and intrahepatic cholangiocarcinoma: Deletion of the other most upregulated gene in myCAF, hyaluronan synthase 2 (Has2), significantly reduces ICC tumor growth with an unknown mechanism due to the multiple hyaluronan receptors and multiple cell types of Has2-expressing myCAF (21).